70470 Federal Register / Vol. 69, No. 233 / Monday, December 6, 2004 / Notices 

Freedom of Information Act 

Considerations: Public comments 

submitted for this planning effort, 

including names and street addresses of 

respondents, will be available for public 

review at the Anchorage Field Office 

during regular business hours (7:30 a.m. 

to 4 p.m.), Monday through Friday, 

except holidays. All submissions from 

organizations or businesses, and from 

individuals identifying themselves as 

representatives or officials of 

organizations or businesses, will be 

made available for public inspection in 

their entirety. Individual respondents 

may request confidentiality. If you wish 

to withhold your name or address from 

public review or from disclosure under 

the Freedom of Information Act, you 

must state this prominently at the 

beginning of your comments. Such 

requests will be honored to the extent 

allowed by law.

June Bailey, 

Field Office Manager.

[FR Doc. 04–26725 Filed 12–3–04; 8:45 am] 

BILLING CODE 4310–$$–P

DEPARTMENT OF JUSTICE

Office of Justice Programs 

[OJP (OVW) Docket No. 1414] 

Notice of Cancellation of Meeting

AGENCY: Office on Violence Against 

Women, DOJ.

ACTION: Notice of cancellation of 

meeting. 

SUMMARY: This notice cancels the public 

meeting of the National Advisory 

Committee on Violence Against Women 

scheduled for December 7, 2004, from 

8:30 a.m. to 4 p.m.

DATES: The cancelled meeting was 

scheduled to take place on December 7, 

2004, from 8:30 a.m. to 4 p.m.

FOR FURTHER INFORMATION CONTACT: Jana 

Sinclair White, The National Advisory 

Committee on Violence Against Women, 

810 Seventh Street, NW., Washington, 

DC, 20531; by telephone at: (202) 353–

4343; e-mail: Jana.S.White@usdoj.gov;

or fax: (202) 307–3911. You may also 

view the Committee’s Web site at:

http://www.ojp.usdoj.gov/vawo/nac/

welcome.html.

Dated: November 30, 2004. 

Margaret Davis, 

Principal Deputy Director, Office on Violence 

Against Women.

[FR Doc. 04–26683 Filed 12–3–04; 8:45 am] 

BILLING CODE 4410–18–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application; 

Correction 

By Notice dated June 28, 2004, and 

published in the Federal Register on 

July 13, 2004, (69 FR 42067–42068), 

dated April 29 2004, the listing of 

controlled substances for Oxycodone 

(9143) and Hydrocodone (9193), were 

inadvertently omitted, by Cedarburg 

Pharmaceuticals, Inc., 870 Badger 

Circle, Grafton, Wisconsin 53024.

Dated: November 22, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–26734 Filed 12–3–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Importation of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(1)), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in Schedule I or II and prior 

to issuing a registration under 21 U.S.C. 

952 (a)(2)(b) authorizing the importation 

of such substances, provide 

manufacturers holding registrations for 

the bulk manufacture of the substances 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on 

September 20, 2004, Johnson Matthey 

Inc., Pharmaceutical Materials, 2003 

Nolte Drive, West Deptford, New Jersey 

08066, made application by renewal to 

the Drug Enforcement Administration 

(DEA) for registration as an importer of 

the basic classes of controlled 

substances:

Drug Schedule 

Phenylacetone (8501) .................. II 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670).

II 

The company plans to import the 

listed controlled substances as raw 

materials for use in the manufacture of 

bulk controlled substances for 

distribution to its customers. 

Any manufacturer who is presently, 

or is applying to be, registered with DEA 

to manufacture such basic classes of 

controlled substances may file written 

comments or objections to the issuance 

of the proposed registration and may, at 

the same time, file a written request for 

a hearing on such application pursuant 

to 21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections or 

requests for hearing may be addressed, 

in quintuplicate, to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, United States 

Department of Justice, Washington, DC 

20537, Attention: DEA Federal Register

Representative, Office of Liaison and 

Policy (ODLR) and must be filed no later 

than January 5, 2005. 

This procedure is to be conducted 

simultaneously with and independent 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import basic class of any 

controlled substance in Schedule I or II 

are and will continue to be required to 

demonstrate to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied.

Dated: November 22, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–26735 Filed 12–3–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to section 1301.33(a) of Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on September 

20, 2004, Johnson Matthey, Inc., Custom 

Pharmaceuticals Department, 2003 

Nolte Drive, West Deptford, New Jersey 

08066, made application by renewal to 

the Drug Enforcement Administration 

(DEA) for registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed:

Drug Schedule 

Tetrahydrocannabinols (7370) ...... I 

Difenoxin (9168) ........................... I 

Propiram (9649) ............................ I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II